자궁경 검사 시술 시장 규모, 점유율, 동향 분석 보고서 : 시술별, 용도별, 지역별, 부문별 예측(2026-2033년)

Hysteroscopy Procedures Market Summary

The global hysteroscopy procedures market size was estimated at USD 14.7 billion in 2025 and is projected to reach USD 21.6 billion by 2033, growing at a CAGR of 4.8% from 2026 to 2033. The increasing prevalence of gynecological disorders, such as uterine abnormalities, abnormal uterine bleeding, uterine fibroids, polyps, and other fertility disorders, is a key factor driving the hysteroscopy procedures industry growth.

Moreover, the rising adoption and awareness of minimally invasive surgeries over traditional methods and technological advancements in hysteroscopy devices are other major factors fueling the market growth. The rising incidence of uterine cancer has increased the number of hysteroscopy procedures, thereby accelerating market growth. In the U.S., endometrial cancer, affecting the uterine lining, ranks as the primary cancer among female reproductive organs. The American Cancer Society projects for 2024 reveal that approximately 67,880 new cases of uterine cancer will be diagnosed, with around 13,250 women falling victim to this condition. Predominantly affecting post-menopausal women, endometrial cancer typically occurs around the age of 60 on average. Presently, there are over 600,000 survivors of endometrial cancer in the U.S.

Technological progress has resulted in the development of advanced miniature hysteroscopes with high-definition capabilities. These devices enable hysteroscopy to be conducted safely and efficiently in office settings while maintaining excellent optical quality. For instance, a study published by BioMed Central in February 2024 indicates that infertile women might benefit from office hysteroscopy prior to undergoing artificial reproductive technology (ART), regardless of previous imaging results not detecting intrauterine abnormalities. Detecting and treating lesions like endometrial polyps, submucosal fibroids, and endometritis through hysteroscopy could enhance live births and clinical pregnancy rates linked with ART. Given that these lesions can adversely affect pregnancy outcomes, their identification and treatment with hysteroscopy should be considered.

Nowadays, minimally invasive surgical procedures are gaining popularity owing to the reduced risk. Minor incisions, reduced postoperative pain, and speedy recovery are leading to high adoption of these procedures. Hysteroscopy is associated with reduced hospitalizations, faster recovery, and less blood loss. Moreover, hysteroscopy induces fewer complications during surgery and a low risk of abdominal wounds.

For instance, according to Medical Xpress, in December 2022, Skoltech and KU Leuven researchers created a gynecological training simulator for in-office hysteroscopy with tactile feedback. This innovation enables gynecologists to practice minimally invasive procedures effectively. Thus, an increase in patient preference for noninvasive or minimally invasive treatments, along with the benefits these techniques offer, is anticipated to boost market growth at a significant rate during the forecast period.

Global Hysteroscopy Procedures Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hysteroscopy procedures market report based on the procedure, end use, and region:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Diagnostic Hysteroscopy
• Polypectomy / Targeted Biopsy
• IUD / Foreign Body Removal
• Tubal Cannulation / Recanalization
• Myomectomy
• Endometrial Ablation
• Other
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Procedure outlook
  • 2.2.2. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Hysteroscopy Procedures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of gynecological disorders
    • 3.2.1.2. Rising adoption of minimally invasive surgical procedures
    • 3.2.1.3. Growing adoption of technologically advanced devices for hysteroscopy procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of hysteroscopy procedures and systems
    • 3.2.2.2. Concerns associated with product approval and commercialization
• 3.3. Hysteroscopy Procedures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Hysteroscopy Procedures Market: Procedure Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Hysteroscopy Procedures Market: Procedure Movement Analysis
• 4.3. Hysteroscopy Procedures Market by Procedure Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
• 4.5. Diagnostic Hysteroscopy
  • 4.5.1. Diagnostic Hysteroscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Polypectomy/Targeted Biopsy
  • 4.6.1. Polypectomy/Targeted Biopsy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. IUD / Foreign Body Removal
  • 4.7.1. IUD / Foreign Body Removal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Tubal Cannulation/Recanalization
  • 4.8.1. Tubal Cannulation/Recanalization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Myomectomy
  • 4.9.1. Myomectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Endometrial Ablation
  • 4.10.1. Endometrial Ablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Others
  • 4.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hysteroscopy Procedures Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Hysteroscopy Procedures Market: End Use Movement Analysis
• 5.3. Hysteroscopy Procedures Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2025 to 2033, for the following
• 5.5. Hospitals
  • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Clinics
  • 5.6.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Ambulatory Surgery Centers
  • 5.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hysteroscopy Procedures Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Hysteroscopy Procedures Market movement analysis
• 6.3. Hysteroscopy Procedures Market: Regional Estimates & Trend Analysis by Procedure & End-use
• 6.4. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
• 6.5. North America
  • 6.5.1. North America Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Canada Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. UK Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Germany Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. France Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. Italy Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Spain Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Denmark Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Reimbursement scenario
    • 6.6.8.5. Sweden Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Reimbursement scenario
    • 6.6.9.5. Norway Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. Japan
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Japan Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. China Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. India Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. South Korea Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Australia Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Thailand Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. Brazil Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Argentina Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. South Africa Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Reimbursement scenario
    • 6.9.3.5. Saudi Arabia Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. Reimbursement scenario
    • 6.9.4.5. UAE Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Reimbursement scenario
    • 6.9.5.5. Kuwait Hysteroscopy Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Medtronic
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Stryker Corporation
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Hologic, Inc.
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. KARL STORZ SE & CO. KG
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Medical Devices Business Services Inc. (Ethicon, Inc)
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Olympus Corp.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Delmont Imaging
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. B. Braun Melsungen AG
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Richard Wolf GmbH
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. CooperCompanies
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Maxer Endoscopy GmbH
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. Boston Scientific Corp.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. MedGyn Products, Inc.
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives
  • 7.2.14. Lina Medical APS
    • 7.2.14.1. Company overview
    • 7.2.14.2. Financial performance
    • 7.2.14.3. Product benchmarking
    • 7.2.14.4. Strategic initiatives
  • 7.2.15. Luminelle
    • 7.2.15.1. Company overview
    • 7.2.15.2. Financial performance
    • 7.2.15.3. Product benchmarking
    • 7.2.15.4. Strategic initiatives
  • 7.2.16. Meditrina, Inc. (Aveta)
    • 7.2.16.1. Company overview
    • 7.2.16.2. Financial performance
    • 7.2.16.3. Product benchmarking
    • 7.2.16.4. Strategic initiatives